FFA
CLBT icon

Farther Finance Advisors’s Cellebrite CLBT Stock Holding History

Farther Finance Advisors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98.8K Buy
6,765
+6,669
+6,947% +$88.1K ﹤0.01% 2713
2026
Q1 		$1.33K Buy
+96
New +$1.45K ﹤0.01% 5030

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Farther Finance Advisors's CLBT Position: Q2 2026 in Review

Farther Finance Advisors increased its Cellebrite (CLBT) stake by 6,947% in Q2 2026, buying an estimated $88.1K and bringing the position to 6,765 shares worth $98.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2713.

Farther Finance Advisors first reported a position in CLBT in Q1 2026 and has held it in 2 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Farther Finance Advisors held 6,765 shares of Cellebrite worth $98.8K as of Q2 2026.
  • Farther Finance Advisors bought 6,669 Cellebrite shares in Q2 2026, an estimated $88.1K.
  • Cellebrite made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #2713 holding.
  • Farther Finance Advisors first reported a position in Cellebrite in Q1 2026 and has held it in 2 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.